Abstract
Background
Caesarean sections (CS) rates are constantly increasing. Despite being a life-saving procedure, this uncontrolled rise remains questionable. While international data suggest that increasing CS rates up to 10–15%, at the population level, is associated with a reduction of maternal and neonatal mortality, the benefit of higher CS rates remains debated.
Methods
The aim of this study was to describe trends of delivery by CS, using the Robson classification and to assess maternal and perinatal outcomes accordingly to identify potential strategies to control the rise in CS rates. This retrospective observational study included all births ≥ 22 weeks of gestation that occurred in a tertiary university hospital in Besançon, France, from January 1st, 2017, to December 31st, 2023. All deliveries were classified using Robson Ten Group Classification System (TGCS). Relative size, CS rate and contribution to the overall CS rate were described for each group. Secondary outcomes were rates of adverse maternal and perinatal outcomes.
Results
A total of 19 082 women were included. The 7-year mean CS rate was 14.4% (n = 2753). A significant reduction of the overall CS rate from 15.4 to 13.0% (95% CI 0.5–4.2%) was observed between 2020 and 2023. This reduction was related to a significant reduction in overall CS rate among group 5 and an important trend towards reduction in group 6.
The cesarean rate in group 1 remained stable over the period at 8% on average. During the study period, an increase in induction rates was observed. Maternal and perinatal outcomes were stable. A significant reduction of neonatal transfer was observed between 2020 and 2023 (1.4%; 95%CI 0.5-2.3%).
Conclusions
An average CS rate below 15% was achieved without increasing maternal and neonatal complications in a tertiary university hospital. Potential target interventions include a better management of women with a previous CS and breech deliveries.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12978-025-02052-8.
Keywords: Caesarean section, Maternal and neonatal outcomes, Induction of labor, Robson classification, Ten-Group Classification System
Background
Caesarean sections (CS) rates have been rising over the past decades to the point of becoming a major health issue [1]. This rise has been particularly marked in high-income countries, with an increase from 23 to 32% in the USA and from 11 to 25% in Europe observed between 1990 and 2014 [2]. Reasons for this increase are likely multifactorial and remain unclear. Despite being a life-saving procedure, CS are associated with a significant increase in maternal and neonatal morbidity, especially when performed without medical indication [3, 4]. Interestingly, a recent survey based on 159 countries highlighted that increasing CS rates up to 10–15%, at the population level, was associated with a reduction of maternal, neonatal and infant mortality, but above this rate there was no decrease in mortality, particularly in high income countries [5].
As such questions remain regarding the ideal CS rate insuring the best maternal and neonatal outcomes, particularly in countries with proper access to obstetrical surgical care. Systematic analyses are required. In that context, the WHO has recommended, since 2015, the use of the Robson classification to systematically monitor CS rates. Although imperfect, this classification, based on ten mutually exclusive groups, appears to be the most suitable and simple method to allow objective comparisons and assessments of obstetrical practices [6, 7]. CS rates in France have been stable over the last decades reaching 21.4% in 2021, but disparities exist depending on the center [8]. Our team already published in 2015 on the reduction in the cesarean section rate and the changes in practices that led to this decrease [9]. We sought to systematically describe CS rates’ trends over the last 7 years in a level III French maternity, with CS rates historically below the national level, and assess maternal and neonatal outcomes accordingly.
Materials and methods
Study population and design
This retrospective study included all pregnant women who delivered at the Besançon University hospital from January 1st, 2017, to December 31st, 2023. All births, including stillbirths, ≥ 22 weeks of gestation were included. The Besançon University hospital is the tertiary referral center for the Franche-Comté region. This region recorded 10 920 deliveries in 2022 for 1 175 600 inhabitants [10]. Data were collected from our electronic database, which includes information regarding maternal and immediate neonatal outcomes. Births were systematically classified according to the Robson Ten Group Classification system. Spontaneous labor was defined as the association of painful regular uterine contractions and a cervical dilatation of 3 cm. In case of labor induction, the Bishop score was used to assess cervical ripening. Prostaglandins or balloon catheters were used primarily in cases of Bishop Score < 6; the use of the balloon was preferred in cases of scarred uterus. The use of oxytocin in labor was based on the 2017 French recommendations [11]. The decisions regarding the timing of the induction labor, or pre-labor CS were collegially validated during an obstetrical staff meeting that takes place every morning.
Outcomes
The primary outcome was the CS rate. Relative size, CS rate and contribution to the overall CS rate were described for each group. Secondary outcomes included (1) rates of adverse maternal outcomes defined as postpartum hemorrhages (PPH) > 1000 cc, obstetrical anal sphincter injury (OASIS) defined according to the WHO classification, rates of uterine rupture, defined clinically and (2) rates of adverse neonatal outcomes defined as arterial pH at birth < 7.0, 5 mn APGAR score < 7 and neonatal transfer to neonatal intensive care unit (NICU). Only transfers from the labor room to the NICU for newborns ≥ 35 weeks of gestation and ≥ 1800 g were considered as adverse neonatal outcomes since newborns born at an earlier GA or with a lower weight were systematically transferred to the NICU.
Statistical analysis
Absolute risks and the 95% confidence intervals (95%CIs) were estimated using the binomial Wilson score and compared as risk differences (RD) with the relevant 95% CIs. Groups were compared using the chi-squared test. Correlation was assessed using the Pearson correlation coefficient. A P value inferior to 0.05 was considered statistically significant. The analyses were performed using Stata 14 (Stata Corporation, College Station, TX, USA).
Results
Between January 1st, 2017 and December 31st, 2023, 19,082 deliveries were recorded at the Besançon University Hospital. Characteristics of the population for each year are presented in Table 1. From 2017 to 2023, we observed an increased proportion of women with a BMI > 25, women > 35 years old and nulliparous women. All patients were classified according to the Robson classification.
Table 1.
Population characteristics for each year of the study period
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Maternal age | |||||||
| <20 | 67 (2.4) | 69 (2.5) | 65 (2.4) | 51 (1.9) | 57 (2.1) | 47 (1.7) | 56 (2.1) |
| 20–24 | 346 (12.4) | 369 (13.3) | 341 (12.8) | 327 (12.1) | 314 (11.3) | 328 (11.9) | 340 (12.8) |
| 25–29 | 914 (32.9) | 890 (32.2) | 807 (30.4) | 880 (32.6) | 834 (30.1) | 846 (30.7) | 786 (29.6) |
| 30–34 | 911 (32.8) | 898 (32.5) | 906 (34.1) | 884 (32.8) | 960 (34.7) | 929 (33.7) | 925 (34.8) |
| ≥ 35 | 542 (19.5) | 539 (19.5) | 537 (20.3) | 556 (20.6) | 602 (21.7) | 610 (22.1) | 549 (20.6) |
| Mean ± SD | 29.9 ± 5,3 | 29.9 ± 5,3 | 30.1 ± 5,3 | 30.1 ± 5,2 | 30.4 ± 5,2 | 30.4 ± 5,3 | 30.2 ± 5,3 |
| BMI | |||||||
| <18.5 | 182 (6.7) | 209 (7.7) | 198 (7.5) | 152 (5.7) | 169 (6.2) | 173 (6.3) | 161 (6.1) |
| 18.5–24.9 | 1532 (56.6) | 1482 (54.3) | 1370 (51.7) | 1483 (55.2) | 1433 (52.3) | 1391 (50.6) | 1350 (51.0) |
| 25–29.9 | 603 (22.3) | 647 (23.7) | 642 (24.2) | 625 (23.2) | 667 (24.3) | 691 (25.1) | 643 (24.3) |
| 30–34.9 | 245 (9.0) | 269 (9.9) | 275 (10.4) | 272 (10.1) | 295 (10.8) | 310 (11.3) | 296 (11.2) |
| ≥35 | 146 (5.4) | 122 (4.5) | 164 (6.2) | 157 (5.8) | 177 (6.5) | 185 (6.7) | 196 (7.4) |
| Mean ± SD | 24.2 ± 5,6 | 24.2 ± 5,8 | 24.6 ± 5,5 | 24.5 ± 5,4 | 24.8 ± 6,0 | 24.9 ± 5,9 | 25.1 ± 6,1 |
| Missing data | 72 (2.6) | 36 (1.3) | 7 (0.3) | 9 (0.3) | 26 (0.9) | 10 (0.4) | 20 (0.8) |
| Parity | |||||||
| 0 | 1174 (42.2) | 1129 (40.8) | 1123 (42.3) | 1222 (45.3) | 1180 (42.6) | 1213 (43.9) | 1176 (44.3) |
| 1 | 975 (35.1) | 996 (36.0) | 890 (33.5) | 831 (30.8) | 928 (33.5) | 911 (33.0) | 876 (33.0) |
| 2 | 631 (22.7) | 640 (23.1) | 643 (24.2) | 645 (23.9) | 659 (23.8) | 636 (23.0) | 604 (22.7) |
| Birth weight (g) | |||||||
| <2000 | 183 (6.4) | 179 (6.4) | 181 (6.7) | 176 (6.3) | 199 (7.0) | 166 (5.9) | 151 (5.6) |
| 2000–2999 | 733 (25.7) | 702 (24.8) | 682 (25.2) | 659 (23.8) | 691(24.6) | 748 (26.5) | 709 (26.1) |
| 3000–3999 | 1748 (61.3) | 1724 (61.0) | 1639 (60.5) | 1722 (62.3) | 1742 (62.0) | 1731 (61.4) | 1692 (62.2) |
| ≥4000 | 189 (6.6) | 223 (7.9) | 209 (7.7) | 208 (7.5) | 178 (6.3) | 173 (6.1) | 167 (6.1) |
| Mean ± SD | 3156 ± 690 | 3160 ± 696 | 3169 ± 726 | 3179 ± 714 | 3156 ± 699 | 3157 ± 670 | 3155 ± 663 |
| Missing data | 12 (0.4) | 8 (0.3) | 14 (0.5) | 11 (0.4) | 13 (0.5) | 23 (0.8) | 21 (0.8) |
BMI Body mass index
The overall CS rate, during the study period, was 14.4%. We observed a trend toward a reduction of the overall CS rate over the study period with a significant reduction observed between 2020 and 2023 from 15.4 to 13.0% (Risk difference (RD) 2.4%; 95% CI 0.5–4.2%) (Fig. 1). Relative size, CS rate and contribution to the overall CS rate according to the Robson classification for each year are presented in the Supplementary material (Tables S1 to S8).
Fig. 1.
Caesarean section (CS) rate in the Ten-Group Classification System (TGCS) over the study period
Over the study period, the largest groups were group 3 (n = 6479, 34%) and group 1 (n = 5148, 27%) followed by groups 5 (n = 1645, 8.6%) and 2a (n = 1545, 8.1%). Significant group size variations were observed between 2017 and 2023: a 2.5% increase (95% CI 1.0–4.0%; p = 0.001), a 3.5% decrease (95% CI 1.0–6.0%; p = 0.0062) and a 1.9% increase (95% CI 0.5–3.2%; p = 0.0058) were observed for groups 2a, 3 and 4a, respectively (Supplementary material Figure S1).
Except for groups 2b, 4b (pre-labor CS) and 9 (transverse lie), the CS rate for each group was < 50%, suggesting a predominance of vaginal delivery in our population. The CS rate of each group remained stable throughout the study period, except for group 2a, in which significant variations were observed (p = 0.036). When looking specifically at the evolution between 2020 and 2023, a significant reduction of the CS rate was observed for group 5 (RD 9.5%; 95% CI 0.7–18.3%; p = 0.0351) and an important trend towards reduction for group 6 (RD 16%; 95%CI −0.8−32.8%; p = 0.0662), while a significant reduction of 24.1% (95%CI 7.3–40.8%, p = 0.0063) was observed between 2017 and 2023 in group 6 (Fig. 1). When looking at the relative contribution of each group to the overall CS rate throughout the years, the largest relative contribution to the CS rates was observed for group 5 (n = 611; 22.2%), followed by group 1 (n = 414; 15.0%), group 10 (n = 412; 15.0%) and group 2a (n = 321; 11,7%) (Fig. 2). The largest contribution to the absolute CS rate was observed in group 5 (3.2%), while the absolute contribution to the overall CS rate remained low for group 1 (2.2%), group 10 (2.2%) and group 2a (1.7%) (Fig. 3). While no significant differences in the relative contribution to the overall CS for all other groups were observed throughout the study periods, significant variations were observed for group 2a without a significant trend (p = 0.003) (Fig. 2), highlighting the difference in its size. Similarly, a significant variation in the absolute contribution to the overall CS rate was observed in groups 2a and 10 (Fig. 3).
Fig. 2.
Relative contribution of each group to the overall caesarean section (CS) rate in the Ten-Group Classification System (TGCS) over the study period
Fig. 3.
Absolute contribution of each group to the overall caesarean section (CS) in the Ten-Group Classification System (TGCS) over the study period
As significant variations were observed in the size of groups 2a and 4a, we further investigated the evolution of induction rates. Induction rates increased significantly over the study period with a 6.0% increase observed from 2017 (n = 463; 16.7%) to 2023 (n = 602; 22.74%) (95% CI 1.2–10.5%; p value = 0.0154). While no significant correlation could be highlighted between induction and CS rates (Pearson correlation coefficient r = − 0.65; p = 0.1136), due to the low numbers of endpoints (n = 7), we observed a strong trend towards an inverted relation between CS and induction rates (Fig. 4).
Fig. 4.
Evolution of induction rate and caesarean section (CS) rate over the study period
Overall maternal and neonatal outcomes are presented in Table 2. Globally, rates of adverse maternal and neonatal outcomes were low. The 7 years rates were 2.1% for postpartum hemorrhages, 0.6% for OASIS, 0.1% for uterine ruptures, 1.2% for APGAR < 7 and 2.2% for neonatal hospitalization among newborns > 35 weeks of gestation and > 1800 g. Neither significant differences, nor trends over time were observed throughout the study period for both maternal and neonatal outcomes, except for neonatal hospitalization rates, which were significantly higher in 2020.
Table 2.
Secondary outcomes for each year of the study period
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n (%) | 95%CI | n (%) | 95%CI | n (%) | 95%CI | n (%) | 95%CI | n (%) | 95%CI | n (%) | 95%CI | n (%) | 95%CI | |
| PPH | ||||||||||||||
| Deliveries | 2780 | 2765 | 2656 | 2698 | 2767 | 2760 | 2656 | |||||||
| PPH >1L | 53 (1.9) | 1.5–2.5 | 52 (1.9) | 1.4–2.5 | 74 (2.8) | 2.2–3.5 | 57 (2.1) | 1.6–2.7 | 68 (2.5) | 1.9–3.1 | 50 (1.8) | 1.4–2.4 | 51 (1.9) | 1.5–2.5 |
| OASIS | ||||||||||||||
| Deliveries | 2780 | 2765 | 2656 | 2698 | 2767 | 2760 | 2656 | |||||||
| OASIS | 13 (0.5) | 0.3–0.8 | 18 (0.7) | 0.4–1.0 | 17 (0.6) | 0.4–1.0 | 23 (0.9) | 0.6–1.3 | 13 (0.5) | 0.3–0.8 | 20 (0.7) | 0.5–1.1 | 13 (0.5) | 0.3–0.8 |
| Uterine ruptures | ||||||||||||||
| Deliveries | 2780 | 2765 | 2656 | 2698 | 2767 | 2760 | 2656 | |||||||
| Uterine ruptures | 5 (0.2) | 0.1–0.4 | 3 (0.1) | 0.0–0.3 | 4 (0.2) | 0.1–0.4 | 5 (0.2) | 0.1–0.4 | 6 (0.2) | 0.1–0.5 | 2(0.1) | 0.0–0.3 | 0 (0.0) | 0.0–0.1 |
| pH | ||||||||||||||
| Total pH at birth | 2678 | 2631 | 2468 | 2574 | 2591 | 2596 | 2448 | |||||||
| pH <7 | 34 (1.3) | 0.9–1.8 | 33 (1.3) | 0.9–1.8 | 43 (1.7) | 1.3–2.3 | 38 (1.5) | 1.1–2.0 | 38 (1.5) | 1.1–2.0 | 45 (1.7) | 1.3–2.3 | 43 (1.8) | 1.3–2.4 |
| APGAR | ||||||||||||||
| Total APGAR at birth | 2833 | 2794 | 2679 | 2731 | 2763 | 2790 | 2696 | |||||||
| APGAR <7 at 5 min | 31 (1.1) | 0.8–1.5 | 35 (1.3) | 0.9–1.7 | 36 (1.3) | 1.0–1.9 | 36 (1.3) | 1.0–1.8 | 30 (1.1) | 0.8–1.5 | 35 (1.3) | 0.9–1.2 | 35 (1.3) | 0.9–1.8 |
| Transfers | ||||||||||||||
| ≥35GA et ≥1800 g | 2648 | 2623 | 2497 | 2568 | 2599 | 2626 | 2546 | |||||||
| NICU transfers | 43 (1.6) | 1.2–2.2 | 43 (1.6) | 1.2–2.2 | 45 (1.8) | 1.4–2.4 | 88 (3.4) | 2.8–4.2 | 67 (2.6) | 2.0–3.3 | 43 (1.6) | 1.2–2.2 | 51 (2.0) | 1.5–2.6 |
Maternal et neonatal outcomes are present for each year of the study period. The 95% confidence intervals (95% CIs) were estimated as proportions using the binomial Wilson score
PPH Post Partum Hemorrhage, OASIS Obstetrical Anal Sphincter Injury, NICU Neonatal Intensive Care Unit
Overall outcomes per Robson group, throughout the study period, are presented in Supplementary material (Table S9). PPH rates were higher among groups 9 (13.7%, 95% CI 7.6–23.4), 2b (9.9%, 95%CI 6.1–15.6), 4b (7.2%, 95% CI 3.7–13.6) and 8 (7.0%, 95% CI 5.1–9.5). OASIS rates were lower among group 3 (0.2%, 95% CI 0.1–0.3) and 4a (0.2%, 95% CI 0.1–0.7) compared to group 1 (1.1%, 95% CI 0.9–1.4) and 2a (1.3%, 95% CI 0.8–2.0), but similar to the other groups. As expected, uterine ruptures were higher among group 5 (1.0%, 95% CI 0.6–1.6%). Regarding neonatal outcomes, pH < 7 was more frequently observed among groups 9 (8.5%, 95% CI 3.7–18.3), 2b (6.1%, 95% CI 3.2–11.1), 7 (6.1%, 95% CI 4.1–9.1) and 6 (3.8%, 95% CI 2.3–6.2) and APGAR < 7 in groups 9 (5.9%, 95% CI 2.3–14.2), 6 (4.9%, 95% CI 3.2–7.4), 7 (4.8%, 95% CI 3.1–7.4), 10 (3.6%, 95% CI 2.6–4.8) and 2b (3.3%, 95% CI 1.4–7.5). Neonatal hospitalizations were more frequent among groups 10 (14.2%, 95% CI 11.5–17.4), 9 (9.1%, 95% CI 3.6–21.2), 8 (7.5%, 95% CI 5.7–9.8), 2b (5.4%, 95% CI 2.7–10.2) and 7 (5.1%, 95% CI 3.1–8.3).
Discussion
Principal findings
The Robson classification was used to evaluate trends in CS rates within a level III university maternity hospital in Besançon, France. An average CS of 15% was maintained over 7 years with stable maternal and neonatal outcomes. Importantly, a significant downward trend in CS rates, reaching 13% in 2023, was observed. By opposition to international data and future forecasts [12] predicting a constant increase in CS rates, our data shows that it is possible to control the CS rates and even to reduce them in a French level III maternity. Our analysis highlighted that this reduction was mostly driven by a significant reduction of CS among group 5 and group 6. Additionally, it is likely that the change in obstetrical practices is associated with an increase in inductions rates.
Results
Our data highlights potential strategies to control the constant rise in CS rates worldwide. Among them is reducing the number of repeated CS among women with a previous CS. Similarly to what is reported worldwide, group 5 was the largest contributor to the relative and absolute CS rates. Nevertheless, the stability of the size of group 5 over the study period underlines the importance given in our unit to promote vaginal deliveries for patients with a previous CS and reducing the number of patients with multi-scarred uterus, for whom the management of childbirth is much more difficult and riskier. As such, the absolute contribution to the overall CS rates was lower (3.2%) than what has been reported in other high income countries (4 to 10.0%) [13, 14]. In our institution, all patients with a scarred uterus are seen by an obstetrician to discuss the mode of delivery, which is subsequently validated in our multidisciplinary obstetrical staff. No ultrasound criteria, particularly the measurement of the thickness of the lower segment, are used to select candidates for a trial of labor after cesarean (TOLAC), as suggested by others [15]. Furthermore, a single previous CS is not a contraindication to induction in our center, for which balloon ripening, artificial rupture of the membranes or oxytocin may be used. Like other patients, they can benefit from a two-day cervical ripening phase using a balloon, before using oxytocin. There is no contraindication to attempt a vaginal delivery even if fetal macrosomia is suspected, and they can continue beyond the term of pregnancy to maximize spontaneous onset of labor. Oxytocin can be used to for labor augmentation with adequate monitoring of the contractions; if needed an internal tocometry is used. Patients with double-scarred uteri are allowed to attempt a vaginal delivery but only if labor begins spontaneously. We strive to give these patients the best possible chance of a natural birth, and the management of the various stages of labor is similar to that of other patients except oxytocin for labor augmentation is not used. Oral consent is obtained, and patients are warned of the higher risk of emergency CS and uterine rupture during TOLAC. A major fear of TOLAC is the risk of uterine rupture. Interestingly, despite having a higher rate of vaginal birth after CS, the number of uterine ruptures was low (i.e. 3–4 cases per year) and comparable to what is reported in literature [16]. During the study period, uterine ruptures were clearly predominantly represented in group 5. Given the very low number of events, no conclusions can be drawn, but neither the use of oxytocin nor the induction of labor appeared to be a determining factor in the occurrence of the rupture in this group. Our findings further strengthen the importance of providing adequate care to women with a previous CS as these represent the main driver of the overall CS rate. Recent European data [14], indeed, demonstrated similar findings, with countries achieving CS rates below 30%, having an absolute contribution to the CS rate of group 5 < 10%, compared to countries with a higher rate of CS for which the contribution of group 5 could reach 10 to 18%.
Another important target is the management of non-cephalic presentations. We observed a significant reduction in the CS rate of group 6 over the study period, which may have contributed to the reduction in the overall CS rate observed. Our institution does have a strong policy of promoting vaginal breech delivery. During the study period, vaginal breech deliveries were achieved in 52% and 63% among primiparous and multiparous, respectively. The Hannah study [17] demonstrated an increased perinatal morbi-mortality in the case of vaginal breech delivery, leading to the abandonment of this practice in many centers worldwide. Since then, other studies have demonstrated, that among selected candidates there was no increased risk of immediate adverse neonatal outcomes in the case of planned vaginal deliveries [18]. Similarly, we did not observe an increased risk of adverse outcomes despite a 24% reduction of CS rate among group 6. In our unit, selection of candidates is based on the French national recommendations and the protocol has been previously published [19, 20]. Precisely, all cases are discussed within our obstetrical multidisciplinary meeting. Primiparous benefit from a pelvimetry CT-scan, while twins and multiparous women with a previous uncomplicated vaginal birth are allowed a trial of labor without a prior pelvimetry. Induction may be offered in case of a favorable cervix. Additionally, since 2019, we have established a city-hospital obstetric staff, allowing independent professionals (midwives and doctors) to be involved in the discussion regarding the mode of delivery, which may facilitate adherence.
Thirdly, although the design of this study does not allow us to draw any definite relation between the induction and the CS rates, we did observe a significant increase in the induction rate, going from 16.7% in 2017 to 22.7% in 2023. The ARRIVE trial suggested a positive benefit of induction among low-risk nulliparous women on CS rates [21] an effect that was further confirmed in a larger observational study [22]. Our data regarding induction rates follow the national and international trends following the publication of the ARRIVE trial. This increase is mainly linked to a re-evaluation of our induction protocols, particularly for fetal growth disorders (IUGR and macrosomia), in line with international recommendations encouraging induction at 39 weeks of gestation. Moreover, the increased proportion of women with a BMI > 25 kg.m2 women > 35 years old and nulliparous women from 2017 to 2023 contribute to increase our induction rate for maternal indications. Therefore, we may suspect that this contributed to the overall reduction in the CS rates observed.
Clinical implications
Collegial decisions among staff and the daily morning review of obstetrical records allow the team to constantly consider the need for CS so as not to trivialize it. As, the CS-rate in group 1 remained stable during the period, and the size of group 5 did not increase, we are now benefiting from the results of a policy favorable to vaginal delivery for several years, which creates a virtuous circle. We also have very few requests for CS on maternal request. While CS on maternal request would be considered, these situations are discussed as early as possible in collaboration with the private practitioner in charge of the pregnancy, during weekly community-hospital staff meetings. The prevalence of adverse maternal outcomes was lower than described in the French perinatal survey [8]. The prevalence of an umbilical cord arterial pH < 7, which defined pathological fetal acidaemia [23] in our study ranged between 1.3% and 1.8%, and the proportion of newborn with an APGAR < 7 at 5 min of life was stable during the period with an average rate over the 7 years of 1.2%. This proportion is slightly lower than what was reported in the 2021 French perinatal survey and recent Swedish data [8, 24]. Although pH values have a low predictive value for neonatal morbidity [25, 26], they remain commonly used to guide neonatal care and are often used in case of a legal issue. Therefore, this parameter is frequently used to assess obstetrical practice. The diagnostic criteria for neonatal hypoxic-ischemic encephalopathy are more complex and depend on pathologic acidemia, low APGAR score, presence of multiple organ-system failures, and clinical evidence of encephalopathy [27]. The rate of NICU transfer, which may reflect more on the neonatal well-being, was low during the study period. 2.2%, in comparison to what has been reported in other studies [28–30].
One of the main concerns of CS is respiratory distress of the newborn, which is 2 to 3 times higher compared to vaginal births [31]. Interestingly, we observed a higher rate of neonatal transfer the same year as our highest rate of CS. While we cannot exclude that more newborns were transferred in the context of the SARS-CoV-2 pandemic, an increased prevalence of respiratory distress may have played a role. No difference in NICU admission rates was observed in our study. Nevertheless, due to the retrospective nature of the study and the rarity of the outcome, we cannot exclude that the study was not powered enough to detect a significant difference. Interestingly, a large Norwegian cohort study recently showed a reduction of fetal intrapartum, perinatal, and neonatal mortality rates associated with a reduction of CS rates from 2008 to 2018, with CS rates similar to ours [32]. A recent large meta-analysis published in 2023 compared maternal and neonatal outcomes in case of planned CS versus a trial of labor. In this review, a planned CS was associated with a reduction of low umbilical artery pH, birth trauma, hypotonia, and chorioamnionitis. Nevertheless, similarly to our results APGAR score and NICU admissions were similar in the two groups. In term of maternal outcomes, urinary incontinence and painful perineum was more frequent in the trial of labor group. Wound infections were more frequent in case of a planned CS; global pain score was not assessed. This meta-analysis reinforces the importance of providing a comprehensive review of the risk and benefit of one birth method versus another to allow an informed choice [33]. Similarly, CS is known to be associated with increased blood loss for the mother [34]. Recent studies on PPH reported an increasing incidence over the last decades, particularly in high-income countries, with a doubling rate reported in several countries, reaching 2–10% [35, 36]. Although multifactorial, the impact of increasing CS rates is questionable. In our study, groups with a higher rate of CS presented a higher risk of PPH. Similar findings were observed among the Swedish population, with the highest absolute rates of PPH observed in group 4b and the lowest in group 3 [36].
Finally, questions remain about the optimal mode of delivery in case of preterm delivery. The Robson classification was originally designed for term pregnancies and may not fully capture the complexity and clinical nuances of preterm labor and delivery. Preterm births often have different clinical indications for cesarean section, such as fetal distress or maternal complications, which may not be fully differentiated within the Robson 10 group (All cephalic births under 37 weeks of gestation). When analyzing preterm births with the Robson classification, it is important to supplement with additional clinical data to understand the context of delivery decisions. Thus, researchers and clinicians should be cautious in interpreting cesarean rates in preterm groups, considering the higher clinical complexity. The available body of evidence does not allow specific recommendations about the choice of mode of delivery regardless of fetal presentation [37]. This lack of recommendation explains worldwide disparities in CS rates in group 10 [14, 38]. Although the absolute contribution to the overall CS rate was high in our unit (2.2%), underlining the high number of preterm births managed in our center, the CS rate in this group was 31.6% and comparable to what is reported in other countries with low CS rates [14]. Although we did not report long-term evolution, our good immediate neonatal outcomes in this group are encouraging regarding the possibility of vaginal delivery in case of preterm birth.
Research implications
While we cannot conclude on an ideal rate of CS, which may not exist and might depend on the local population and obstetrical practices, our study may help other centers assess their own rates. Additional international systematic studies are needed to better describe CS rates and related maternal and neonatal outcomes. The WHO has launched a platform that should facilitate such analysis [39]. Studies should also focus on assessing long-term outcomes. These are necessary (1) for local quality control and center-dependent improvement of practices and (2) for further understanding factors implicated in CS rates at a global level and optimization of obstetrical practices to improve maternal and neonatal outcomes. The role of induction of labor should be specifically tackled. Although it may be associated with a reduction of CS. Specific candidates who may benefit from induction remain to be better defined. Additionally, the impact on other maternal and neonatal outcomes should be assessed. Particularly, potential association with PPH and maternal experience should be considered.
Strengths and limitations
The major strength of this study is the exhaustive collection of data regarding the Robson classification and the low number of missing data for the different judgment criteria, enabling a comprehensive analysis over a 7-year period. At this time, our results are the only data from a French university maternity hospital to be declared on the WHO platform [39]. Several limitations need to be acknowledged. Firstly, our analysis focused on the Robson classification, which relies on minimal characteristics that are not enough to explain CS rates. As such, information regarding indication for induction of labor, indication for CS delivery, fetal complications (e.g., growth restriction, anatomical anomalies) and maternal comorbidities such as diabetes and preeclampsia were not reported. However, our population is comparable to other level III maternity units in France in terms of maternal age, BMI, parity and birth weight of newborns, allowing comparisons [8]. Secondly, our analysis focused on a limited number of maternal and neonatal outcomes routinely collected in our databases. Rates of neonatal trauma, such as fractures and hematoma were not considered. These are often diagnosed within the first days of life and recorded in the newborns’ charts, making them difficult to assess using routine obstetrical files. Thirdly, our analysis focused on immediate neonatal and maternal outcomes, limiting conclusions. CS rates cannot be taken as an endpoint on their own and interpreted in views of immediate maternal and neonatal outcomes. Mode of delivery may, indeed, have additional long-term impact. Important aspects that need to be considered are psychological consequences, sexual and continence dysfunctions, chronic pains, future pregnancy complications, impact on children’s neurocognitive development and risk for chronic disease development later in childhood [40]. The maternal experience of childbirth is taking on an increasing role in maternity wards. In our study, maternal satisfaction was not assessed. Nevertheless, in recent years, we have not observed a significant increase in requests for cesarean sections for maternal convenience in our population. On the contrary, our patients increasingly wish to return to a birth with the least possible medical intervention. Informed consent and shared decision making plays a major role in maternal satisfaction. Comprehensive analysis as presented in our study, contributes to the body of data and might help to adequately inform women in order for them to make the best decision regarding the mode of delivery. Finally, we know that the generalization of our data raises questions. Although comparable to the national population in our case, the evolution of maternal characteristics such as BMI is not the same everywhere around the world and can account for the CS-rate results. Moreover, the promotion of the attempt of vaginal delivery concerning non-cephalic presentations and twin pregnancies is based on decades of knowledge transmission, and reversing after the gradual abandonment of such practices is difficult.
Conclusions
A CS rate below 15% was achieved without increasing maternal and neonatal complications in a tertiary university hospital, suggesting that efforts could be made in high-income countries to reduce CS rates. Potential target interventions include better management of women with a previous CS and breech deliveries. Induction of labor among selected candidates might contribute to a reduction of CS rates. The use of the Robson classification was easy to implement and provided important data, allowing the monitoring and improvement of practices.
Supplementary Information
Acknowledgements
Not applicable.
Authors’ contributions
A.B.M and N.M conceived the study. D.R contributed to the creation of the database and its interpretation. J.E and A.B.M collected the data. JE draft the article, MV analyzed the data and supervised the article. All authors discussed the results and contributed to the final manuscript. NM final approval of the version to be published.
Funding
Manon Vouga is supported by the Max Cloëtta foundation and the Vaudoise Academic Society.
Data availability
No datasets were generated or analysed during the current study.
Declarations
Ethics approval and consent to participate
As per French regulations, this retrospective observational study is exempt from institutional review board review due to the use of anonymized data from medical records. In our center, women are systematically informed that obstetrical and neonatal data can be used for the evaluation of medical practices and are explicitly informed that they can sign an opposition form.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Betran AP, Torloni MR, Zhang JJ, Gülmezoglu AM, WHO Working Group on Caesarean Section. WHO statement on caesarean section rates. BJOG. 2016;123:667–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Betrán AP, et al. The increasing trend in caesarean section rates: global, regional and National estimates: 1990–2014. PLoS One. 2016;11:e0148343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Souza JP, et al. Caesarean section without medical indications is associated with an increased risk of adverse short-term maternal outcomes: the 2004–2008 WHO global survey on maternal and perinatal health. BMC Med. 2010;8:71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Villar J, et al. Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study. BMJ. 2007;335:1025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ye J, et al. Association between rates of caesarean section and maternal and neonatal mortality in the 21st century: a worldwide population-based ecological study with longitudinal data. BJOG. 2016;123:745–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Torloni MR, et al. Classifications for Cesarean section: a systematic review. PLoS One. 2011;6:e14566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Betrán AP, Vindevoghel N, Souza JP, Gülmezoglu AM, Torloni MR. A systematic review of the Robson classification for caesarean section: what works, doesn’t work and how to improve it. PLoS One. 2014;9:e97769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Enquête nationale périnatale. 2021. https://www.santepubliquefrance.fr/etudes-et-enquetes/enquete-nationale-perinatale-2021.
- 9.Lembrouck C, Mottet N, Bourtembourg A, Ramanah R, Riethmuller D. Can we decrease cesarean rate at a university hospital treating high risk pregnancies? J Gynecol Obstet Biol Reprod (Paris). 2016;45:641–51. [DOI] [PubMed] [Google Scholar]
- 10.L’offre périnatale de Bourgogne-. Franche-Comté serait confrontée à une baisse des naissances jusqu’en 2030 - Insee Analyses Bourgogne-Franche-Comté – 48. https://www.insee.fr/fr/statistiques/3699365.
- 11.Dupont C, et al. Recommandations pour l’administration d’oxytocine Au cours du travail spontané. Texte court des recommandations. La Revue Sage-Femme. 2017;16:111–8. [DOI] [PubMed] [Google Scholar]
- 12.Betran AP, Ye J, Moller A-B, Souza JP, Zhang J. Trends and projections of caesarean section rates: global and regional estimates. BMJ Glob Health. 2021;6:e005671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Vogel JP, et al. Use of the Robson classification to assess caesarean section trends in 21 countries: a secondary analysis of two WHO multicountry surveys. Lancet Global Health. 2015;3:e260–70. [DOI] [PubMed] [Google Scholar]
- 14.Zeitlin J, et al. Using robson’s Ten-Group classification system for comparing caesarean section rates in europe: an analysis of routine data from the Euro-Peristat study. BJOG: Int J Obstet Gynecol. 2021;128:1444–53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Rozenberg P, Goffinet F, Phillippe HJ, Nisand I. Ultrasonographic measurement of lower uterine segment to assess risk of defects of scarred uterus. Lancet. 1996;347:281–4. [DOI] [PubMed] [Google Scholar]
- 16.ACOG Practice Bulletin No. 205: vaginal birth after cesarean delivery. Obstet Gynecol. 2019;133:e110–27. [DOI] [PubMed] [Google Scholar]
- 17.Hannah ME, et al. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term breech trial collaborative group. Lancet. 2000;356:1375–83. [DOI] [PubMed] [Google Scholar]
- 18.Goffinet F, et al. Is planned vaginal delivery for breech presentation at term still an option? Results of an observational prospective survey in France and Belgium. Am J Obstet Gynecol. 2006;194:1002–11. [DOI] [PubMed] [Google Scholar]
- 19.Benmessaoud I, et al. Analysis of spontaneous labor progression of breech presentation at term. PLoS One. 2022;17:e0262002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pascalet M, et al. Mode of delivery of twin pregnancies with the first twin in breech position after the introduction of a policy of planned caesarean delivery for nulliparous women. Eur J Obstet Gynecol Reprod Biol. 2019;234:58–62. [DOI] [PubMed] [Google Scholar]
- 21.Grobman WA, et al. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med. 2018;379:513–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Gilroy LC, Al-Kouatly HB, Minkoff HL, McLaren RA. Changes in obstetrical practices and pregnancy outcomes following the ARRIVE trial. Am J Obstet Gynecol. 2022;226:e7161–71612. [DOI] [PubMed] [Google Scholar]
- 23.MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ. 1999;319:1054–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Savchenko J, Ladfors L, Hjertberg L, Hildebrand E. Brismar wendel, S. A step towards better audit: the Robson ten group classification system for outcomes other than cesarean section. Acta Obstet Gynecol Scand. 2022;101:827–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Lau SL, et al. Neonatal outcome of infants with umbilical cord arterial pH less than 7. Acta Obstet Gynecol Scand. 2023;102:174–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Vanspranghels R, et al. Umbilical cord arterial and venous gases, ionogram, and glucose level for predicting neonatal morbidity at term. Eur J Obstet Gynecol Reprod Biol. 2020;252:181–6. [DOI] [PubMed] [Google Scholar]
- 27.Gillam-Krakauer M, Gowen CW Jr. Birth asphyxia. In StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. [Google Scholar]
- 28.Braun D, et al. Trends in neonatal intensive care unit utilization in a large integrated health care system. JAMA Netw Open. 2020;3:e205239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Schulman J, et al. Association between neonatal intensive care unit admission rates and illness acuity. JAMA Pediatr. 2018;172:17–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Harrison W, Goodman D. Epidemiologic trends in neonatal intensive care, 2007–2012. JAMA Pediatr. 2015;169:855–62. [DOI] [PubMed] [Google Scholar]
- 31.Hansen AK, Wisborg K, Uldbjerg N, Henriksen TB. Elective caesarean section and respiratory morbidity in the term and near-term neonate. Acta Obstet Gynecol Scand. 2007;86:389–94. [DOI] [PubMed] [Google Scholar]
- 32.Laine K, Pay AD, Yli BM. Time trends in caesarean section rates and associations with perinatal and neonatal health: a population-based cohort study of 1 153 789 births in Norway. BMJ Open. 2023;13:e069562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Adewale V, et al. Planned Cesarean delivery vs planned vaginal delivery: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM. 2023;5:101186. [DOI] [PubMed] [Google Scholar]
- 34.Korb D, Goffinet F, Seco A, Chevret S, Deneux-Tharaux C. Risk of severe maternal morbidity associated with cesarean delivery and the role of maternal age: a population-based propensity score analysis. CMAJ. 2019;191:E352–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Thams AB, Larsen MH, Rasmussen SC, Jeppegaard M, Krebs L. Incidence of postpartum hemorrhage and risk factors for recurrence in the subsequent pregnancy. Arch Gynecol Obstet. 2023;307:1217–24. [DOI] [PubMed] [Google Scholar]
- 36.Ladfors L, Muraca G, Zetterqvist J, Butwick A, Stephansson O. Postpartum haemorrhage trends in Sweden using the Robson ten group classification system: a population-based cohort study. BJOG: Int J Obstet Gynecol. 2022;129:562–71. [DOI] [PubMed] [Google Scholar]
- 37.Mottet N, Riethmuller D. Mode d’accouchement En Cas de prématurité spontanée. J De Gynécologie Obstétrique Et Biol De La Reprod. 2016;45:1434–45. [DOI] [PubMed] [Google Scholar]
- 38.Eftekharian C, Husslein PW, Lehner R. Cesarean section rate and perinatal outcome analyses according to robson’s 10-Group classification system. Matern Child Health J. 2021;25:1474–81. [DOI] [PubMed] [Google Scholar]
- 39.WHO Robson classification platform. https://robson-classification-platform.srhr.org/.
- 40.Sandall J, et al. Short-term and long-term effects of caesarean section on the health of women and children. Lancet. 2018;392:1349–57. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
No datasets were generated or analysed during the current study.